Allison Dorval

Insider Reports History

Entity
Individual
Location
C/O Insulet Corporation, 600 Technology Park Drive, Suite 200, Billerica, MA
Signature
/s/ Gordon Esplin as attorney-in-fact for Allison Dorval
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Allison Dorval:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 45K $450K $10.00 Feb 14, 2024 Direct
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 12.5K $205K $16.37 Jun 5, 2024 Direct
PUMA BIOTECHNOLOGY, INC. Director Common Stock 60K $200K $3.33 Jun 18, 2024 Direct
Verve Therapeutics, Inc. Chief Financial Officer Common Stock 4.06K $40.6K $10.00 Nov 29, 2023 Direct
Verve Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 180K Feb 14, 2024 Direct

Insider Reports Filed by Allison Dorval

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PBYI PUMA BIOTECHNOLOGY, INC. Jun 18, 2024 1 $0 4 Jun 21, 2024 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 13, 2024 1 -$37.1K 4 Jun 17, 2024 Director
AVTE Aerovate Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
VERV Verve Therapeutics, Inc. Feb 14, 2024 2 $0 4 Feb 16, 2024 Chief Financial Officer
VERV Verve Therapeutics, Inc. Nov 29, 2023 3 -$6.34K 4 Dec 1, 2023 Chief Financial Officer
PBYI PUMA BIOTECHNOLOGY, INC. Jun 13, 2023 2 -$34.5K 4 Jun 15, 2023 Director
AVTE Aerovate Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
VERV Verve Therapeutics, Inc. Feb 14, 2023 1 $0 4 Feb 16, 2023 Chief Financial Officer
VERV Verve Therapeutics, Inc. Nov 29, 2022 3 -$12.2K 4 Dec 1, 2022 Chief Financial Officer
AVTE Aerovate Therapeutics, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jun 14, 2022 1 $0 4 Jun 17, 2022 Director
VERV Verve Therapeutics, Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 Chief Financial Officer
VERV Verve Therapeutics, Inc. Nov 29, 2021 2 $0 4 Nov 30, 2021 Chief Financial Officer
VERV Verve Therapeutics, Inc. Nov 29, 2021 0 $0 3 Nov 30, 2021 Chief Financial Officer
AVTE Aerovate Therapeutics, Inc. Jul 15, 2021 1 $0 4 Jul 19, 2021 Director
AVTE Aerovate Therapeutics, Inc. Jul 15, 2021 0 $0 3 Jul 19, 2021 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jul 15, 2021 1 $0 4 Jul 16, 2021 Director
PBYI PUMA BIOTECHNOLOGY, INC. Jul 15, 2021 0 $0 3 Jul 16, 2021 Director